{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T03:59:18Z","timestamp":1780804758675,"version":"3.54.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000},"content-version":"vor","delay-in-days":390,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.blre.2015.06.003","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T03:04:32Z","timestamp":1434596672000},"page":"417-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Hugo J.A.","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger A.J.","family":"Nievelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.blre.2015.06.003_bb0005","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1200\/JCO.2005.05.016","article-title":"State-of-the-art therapeutics: Hodgkin's lymphoma","volume":"23","author":"Connors","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9844","key":"10.1016\/j.blre.2015.06.003_bb0010","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.blre.2015.06.003_bb0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3322\/canjclin.55.6.368","article-title":"Staging non-Hodgkin lymphoma","volume":"55","author":"Armitage","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"10.1016\/j.blre.2015.06.003_bb0020","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.blre.2015.06.003_bb0025","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0030","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The Revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2015.06.003_bb0035","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0040","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular Lymphoma International Prognostic Index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"issue":"27","key":"10.1016\/j.blre.2015.06.003_bb0045","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular Lymphoma International Prognostic Index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project","volume":"27","author":"Federico","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.blre.2015.06.003_bb0050","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00520-012-1639-9","article-title":"Bone marrow involvement is predictive of infusion-related reaction during rituximab administration in patients with B cell lymphoma","volume":"21","author":"Hong","year":"2013","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4657","key":"10.1016\/j.blre.2015.06.003_bb0060","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.1.4657.827","volume":"1","author":"Biopsy","year":"1950","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.blre.2015.06.003_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2007.06749.x","article-title":"Trepanning or trephines: a history of bone marrow biopsy","volume":"139","author":"Parapia","year":"2007","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.blre.2015.06.003_bb0070","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/01.pas.0000182405.65041.8b","article-title":"Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens","volume":"29","author":"Arber","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.blre.2015.06.003_bb0075","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JCO.1990.8.7.1163","article-title":"Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group","volume":"8","author":"Conlan","year":"1990","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.blre.2015.06.003_bb0080","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1399-6576.2008.01874.x","article-title":"Procedure-related pain among adult patients with hematologic malignancies","volume":"53","author":"Liden","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"issue":"9","key":"10.1016\/j.blre.2015.06.003_bb0085","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/jcp.2008.058180","article-title":"Midazolam in conjunction with local anaesthesia is superior to Entonox in providing pain relief during bone marrow aspirate and trephine biopsy","volume":"61","author":"Chakupurakal","year":"2008","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.blre.2015.06.003_bb0090","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/mpo.2950190610","article-title":"Midazolam premedication for pediatric bone marrow aspiration and lumbar puncture","volume":"19","author":"Friedman","year":"1991","journal-title":"Med Pediatr Oncol"},{"issue":"6","key":"10.1016\/j.blre.2015.06.003_bb0095","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/jcp.40.6.696","article-title":"Premedication with lorazepam before bone marrow biopsy","volume":"40","author":"Milligan","year":"1987","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.blre.2015.06.003_bb0100","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2141.2003.04329.x","article-title":"Bone marrow biopsy morbidity and mortality","volume":"121","author":"Bain","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.blre.2015.06.003_bb0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-82-3-365","article-title":"Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases","volume":"82","author":"Brunning","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2015.06.003_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ajh.2830030201","article-title":"Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsies","volume":"3","author":"Coller","year":"1977","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0115","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/mpo.2950170512","article-title":"Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging","volume":"17","author":"Haddy","year":"1989","journal-title":"Med Pediatr Oncol"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0120","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/cncr.10364","article-title":"Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy","volume":"94","author":"Wang","year":"2002","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.blre.2015.06.003_bb0125","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.crad.2013.01.022","article-title":"Influence of imperfect reference standard bias on the diagnostic performance of MRI in the detection of lymphomatous bone marrow involvement","volume":"68","author":"Adams","year":"2013","journal-title":"Clin Radiol"},{"issue":"6","key":"10.1016\/j.blre.2015.06.003_bb0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/jcp.2008.063446","article-title":"Call for a European programme in external quality assurance for bone marrow immunohistochemistry; report of a European Bone Marrow Working Group pilot study","volume":"62","author":"Torlakovic","year":"2009","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.blre.2015.06.003_bb0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2967\/jnumed.109.067892","article-title":"(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients","volume":"51","author":"Weiler-Sagie","year":"2010","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.blre.2015.06.003_bb0140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00259-010-1531-0","article-title":"Radionuclide imaging of bone marrow disorders","volume":"38","author":"Agool","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11307-007-0100-9","article-title":"Age-related changes in the metabolic activity and distribution of the red marrow as demonstrated by 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography","volume":"9","author":"Fan","year":"2007","journal-title":"Mol Imaging Biol"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0150","first-page":"286","article-title":"Evaluation of physiological FDG uptake in the skeleton in adults: is it uniformly distributed?","volume":"33","author":"Aras","year":"2014","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"9","key":"10.1016\/j.blre.2015.06.003_bb0155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s002560050423","article-title":"Magnetic resonance imaging of the normal bone marrow","volume":"27","author":"Vande Berg","year":"1998","journal-title":"Skeletal Radiol"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0160","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/annonc\/mdt533","article-title":"Systematic review and meta-analysis on the diagnostic performance of FDG-PET\/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?","volume":"25","author":"Adams","year":"2014","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.blre.2015.06.003_bb0165","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00259-013-2623-4","article-title":"FDG PET\/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis","volume":"41","author":"Adams","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"27","key":"10.1016\/j.blre.2015.06.003_bb0170","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.blre.2015.06.003_bb0175","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2015.06.003_bb0180","article-title":"Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance","author":"Adams","year":"2014","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.blre.2015.06.003_bb0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood-2012-12-473389","article-title":"PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement","volume":"122","author":"Khan","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2015.06.003_bb0190","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2967\/jnumed.112.114710","article-title":"In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET\/CT provides better diagnostic performance and prognostic stratification than does biopsy","volume":"54","author":"Berthet","year":"2013","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.blre.2015.06.003_bb0195","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2967\/jnumed.113.134486","article-title":"Combined PET and biopsy evidence of marrow involvement improves prognostic prediction in diffuse large B-cell lymphoma","volume":"55","author":"Cerci","year":"2014","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.blre.2015.06.003_bb0200","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12149-009-0286-9","article-title":"A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity","volume":"23","author":"Inoue","year":"2009","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1016\/j.blre.2015.06.003_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12185-013-1473-y","article-title":"Focal 18F-FDG uptake in bone marrow on PET\/CT in a patient with JAK2 mutation without overt myeloproliferative neoplasm","volume":"99","author":"Fujimi","year":"2014","journal-title":"Int J Hematol"},{"issue":"8","key":"10.1016\/j.blre.2015.06.003_bb0210","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/RLU.0b013e31825ae455","article-title":"Gelatinous degeneration of the bone marrow mimicking osseous metastasis on 18F-FDG PET\/CT","volume":"37","author":"Chong","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.blre.2015.06.003_bb0215","first-page":"316","article-title":"G-CSF induces focal intense bone marrow FDG uptake mimicking multiple bone metastases from uterine cervical cancer: a case report and review of the literature","volume":"33","author":"Mabuchi","year":"2012","journal-title":"Eur J Gynaecol Oncol"},{"issue":"3","key":"10.1016\/j.blre.2015.06.003_bb0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajh.23921","article-title":"Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG-PET","volume":"90","author":"Adams","year":"2015","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.blre.2015.06.003_bb0225","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00259-009-1183-0","article-title":"Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?","volume":"36","author":"Salaun","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.blre.2015.06.003_bb0230","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1148\/radiology.219.3.r01ma08774","article-title":"FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions","volume":"219","author":"Aoki","year":"2001","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0235","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2004-01-0379","article-title":"Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma","volume":"105","author":"Vassilakopoulos","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2015.06.003_bb0240","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1365-2141.2002.03842.x","article-title":"The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre","volume":"119","author":"Howell","year":"2002","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.blre.2015.06.003_bb0245","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.blre.2015.06.003_bb0250","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/10428194.2011.616613","article-title":"Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era","volume":"53","author":"Richardson","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"Suppl 3","key":"10.1016\/j.blre.2015.06.003_bb0255","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdu181","article-title":"Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Eichenauer","year":"2014","journal-title":"Ann Oncol"},{"issue":"36","key":"10.1016\/j.blre.2015.06.003_bb0260","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1200\/JCO.2012.42.4036","article-title":"Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography\/computed tomography-staged treatment-naive patients with Hodgkin lymphoma","volume":"30","author":"El-Galaly","year":"2012","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.blre.2015.06.003_bb0265","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.blre.2015.06.003_bb0270","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1200\/JCO.2010.33.3419","article-title":"Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP","volume":"29","author":"Sehn","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.blre.2015.06.003_bb0275","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood-2007-01-070300","article-title":"Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index","volume":"110","author":"Chung","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.06.003_bb0280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/annonc\/mdi050","article-title":"Can patients with early-stage diffuse large B-cell lymphoma be treated without bone marrow biopsy?","volume":"16","author":"Lim","year":"2005","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.blre.2015.06.003_bb0285","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/0284186X.2014.958531","article-title":"Bone marrow biopsy in diffuse large B-cell lymphoma: useful or redundant test?","volume":"54","author":"Adams","year":"2015","journal-title":"Acta Oncol"},{"issue":"Suppl 7","key":"10.1016\/j.blre.2015.06.003_bb0290","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mds273","article-title":"Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Tilly","year":"2012","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.blre.2015.06.003_bb0295","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ajh.23760","article-title":"The utility of restaging bone marrow biopsy in PET-negative patients with diffuse large B-cell lymphoma and baseline bone marrow involvement","volume":"89","author":"Jackson","year":"2014","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0300","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jclinpath-2012-201158","article-title":"Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP","volume":"66","author":"Shim","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.blre.2015.06.003_bb0305","article-title":"Direct comparison of visual and quantitative bone marrow FDG-PET\/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET\/CT live up to its promise?","author":"Adams","year":"2014","journal-title":"Acta Radiol"},{"issue":"7","key":"10.1016\/j.blre.2015.06.003_bb0310","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ajh.23730","article-title":"Bone marrow 18F-fluoro-2-deoxy-d-glucose positron emission tomography\/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma","volume":"89","author":"Adams","year":"2014","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0315","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00277-011-1353-6","article-title":"Role of FDG-PET\/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma","volume":"91","author":"Hong","year":"2012","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.blre.2015.06.003_bb0320","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1182\/blood-2013-05-502575","article-title":"Staging DLBCL: bone marrow biopsy or PET-CT?","volume":"122","author":"Avigdor","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2015.06.003_bb0325","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ajh.23674","article-title":"Follicular lymphoma: 2014 update on diagnosis and management","volume":"89","author":"Freedman","year":"2014","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.blre.2015.06.003_bb0330","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jcp.43.8.630","article-title":"Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma","volume":"43","author":"Juneja","year":"1990","journal-title":"J Clin Pathol"},{"issue":"Suppl 3","key":"10.1016\/j.blre.2015.06.003_bb0335","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Dreyling","year":"2014","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.blre.2015.06.003_bb0340","doi-asserted-by":"crossref","first-page":"916","DOI":"10.6004\/jnccn.2014.0086","article-title":"Non-Hodgkin's lymphomas, version 2.2014","volume":"12","author":"Zelenetz","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"10.1016\/j.blre.2015.06.003_bb0345","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/annonc\/mdt137","article-title":"The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi","volume":"24","author":"Luminari","year":"2013","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.blre.2015.06.003_bb0350","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0969-8051(96)00085-6","article-title":"Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: initial evaluation","volume":"23","author":"Knopp","year":"1996","journal-title":"Nucl Med Biol"},{"issue":"2","key":"10.1016\/j.blre.2015.06.003_bb0355","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00003072-199802000-00007","article-title":"Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging","volume":"23","author":"Hollinger","year":"1998","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.blre.2015.06.003_bb0360","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00259-014-2706-x","article-title":"Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET\/CT","volume":"41","author":"Weiler-Sagie","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.blre.2015.06.003_bb0365","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/RLU.0b013e31828e9504","article-title":"Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET\/CT versus bone marrow biopsy","volume":"39","author":"Cortes-Romera","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.blre.2015.06.003_bb0370","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12149-012-0665-5","article-title":"Role of F-18 FDG PET\/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma","volume":"27","author":"Agrawal","year":"2013","journal-title":"Ann Nucl Med"},{"issue":"1016","key":"10.1016\/j.blre.2015.06.003_bb0375","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1259\/bjr\/29583493","article-title":"Clinical utility of (1)(8)F FDG-PET\/CT in the detection of bone marrow disease in Hodgkin's lymphoma","volume":"85","author":"Muzahir","year":"2012","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.blre.2015.06.003_bb0380","first-page":"469","article-title":"Bone marrow disease detection with FDG-PET\/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study","volume":"55","author":"Pelosi","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.blre.2015.06.003_bb0385","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3109\/10428194.2011.593273","article-title":"Can fluorodeoxyglucose positron emission tomography\/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?","volume":"52","author":"Mittal","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.blre.2015.06.003_bb0390","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s00259-011-1815-z","article-title":"Biopsy versus FDG PET\/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients","volume":"38","author":"Cheng","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.blre.2015.06.003_bb0395","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00259-009-1377-5","article-title":"(18)F-FDG PET\/CT bone\/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging","volume":"37","author":"Moulin-Romsee","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.blre.2015.06.003_bb0400","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/annonc\/mdp030","article-title":"High SUV uptake on FDG-PET\/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET\/CT staging in lymphoma","volume":"20","author":"Ngeow","year":"2009","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.blre.2015.06.003_bb0405","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejrad.2007.06.014","article-title":"Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET\/CT and bone marrow biopsy","volume":"66","author":"Ribrag","year":"2008","journal-title":"Eur J Radiol"},{"issue":"12","key":"10.1016\/j.blre.2015.06.003_bb0410","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00259-010-1539-5","article-title":"Diagnostic and prognostic impact of 18F-FDG PET\/CT in follicular lymphoma","volume":"37","author":"Le Dortz","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.blre.2015.06.003_bb0415","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/annonc\/mdl014","article-title":"18F-Fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading","volume":"17","author":"Wohrer","year":"2006","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.blre.2015.06.003_bb0420","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1124::AID-CNCR16>3.0.CO;2-A","article-title":"Prognosis of patients with advanced Hodgkin's disease: evaluation of four prognostic models using 344 patients included in the Group d'Etudes des Lymphomes de l'Adulte Study","volume":"80","author":"Ferme","year":"1997","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.blre.2015.06.003_bb0425","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3109\/10428194.2013.875169","article-title":"Impact of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement","volume":"55","author":"El-Galaly","year":"2014","journal-title":"Leuk Lymphoma"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X15000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X15000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T18:22:15Z","timestamp":1748456535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X15000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0268960X15000454"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2015.06.003","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2015.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}